These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3928308)

  • 21. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1982 Apr; 49(5):1279-86. PubMed ID: 6801955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tocainide plus quinidine for treatment of ventricular arrhythmias.
    Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
    Am J Cardiol; 1988 Mar; 61(8):570-3. PubMed ID: 3125737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias.
    Nestico PF; DePace NL; Morganroth J
    Med Clin North Am; 1984 Sep; 68(5):1295-319. PubMed ID: 6436595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
    Mahapatra RK; Mahapatra D
    Angiology; 1986 Apr; 37(4):285-93. PubMed ID: 2424347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
    Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
    Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
    MacMahon B; Bakshi M; Branagan P; Kelly JG; Walsh MJ
    Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tocainide.
    Hanyok JJ
    Conn Med; 1985 Dec; 49(12):827-8. PubMed ID: 3936674
    [No Abstract]   [Full Text] [Related]  

  • 32. Tocainide in the cardiac ICU.
    Benning CA; Burke PA
    Crit Care Nurse; 1989 Feb; 9(2):45-53. PubMed ID: 2510974
    [No Abstract]   [Full Text] [Related]  

  • 33. Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents.
    Maloney JD; Nissen RG; McColgan JM
    Am Heart J; 1980 Dec; 100(6 Pt 2):1023-30. PubMed ID: 6778190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tocainide: a new drug for ventricular arrhythmias.
    Volosin KJ; Greenspon AJ
    Am Fam Physician; 1986 Jan; 33(1):233-5. PubMed ID: 3079938
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative hemodynamic effects of procainamide, tocainide, and encainide in severe chronic heart failure.
    Gottlieb SS; Kukin ML; Medina N; Yushak M; Packer M
    Circulation; 1990 Mar; 81(3):860-4. PubMed ID: 2106401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic tocainide or lidocaine in acute myocardial infarction.
    Keefe DL; Williams S; Torres V; Flowers D; Somberg JC
    Am J Cardiol; 1986 Mar; 57(8):527-31. PubMed ID: 3082175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the drug treatment of ventricular arrhythmias.
    Nestico PF; Morganroth J
    Int J Dermatol; 1984 Oct; 23(8):558-64. PubMed ID: 6437997
    [No Abstract]   [Full Text] [Related]  

  • 39. Exacerbation of ventricular tachycardia by tocainide.
    Cheesman M; Ward DE
    Clin Cardiol; 1985 Jan; 8(1):47-50. PubMed ID: 3917881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis of primary ventricular fibrillation with tocainide in acute myocardial infarction.
    Campbell RW; Hutton I; Elton RA; Goodfellow RM; Taylor E
    Br Heart J; 1983 Jun; 49(6):557-63. PubMed ID: 6405764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.